Jing Lin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Transcription Factor

Cancer Stem Cells

Long Noncoding Rna

Top Venues

Current cancer drug targets

Journal of oncology

The 452 Hospital of Western Air Force

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The 452 Hospital of Western Air Force

China

Attending doctor :: Neurosurgery

Publications

Guanzhong Qiu, Chaoli Song, Meiqing Lou, Jing Lin
Decoding the Expressions, Immune Relevance, and Prognostic Values of Ferroptosis Gene TMEM189: A Pan-Cancer Analysis. Current cancer drug targets (2024)
Qiang Liang, Bing Wang, Chenran Zhang, Chaoli Song, Junyu Wang, Wei Sun, Lei Jiang, Jing Lin
EZH2-regulated PARP 1 Expression is a Likely Mechanism for the Chemoresistance of Gliomas to Temozolomide. Current cancer drug targets (2023)
Jing Lin, Lei Jiang, Xiaogang Wang, Wenxin Wei, Chaoli Song, Yong Cui, Xiaojun Wu, GuanZhong Qiu
P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway. Journal of oncology 2021 (2021)
Guan-Zhong Qiu, Xiao-Yuan Mao, Yue Ma, Xing-Chun Gao, Zhen Wang, Ming-Zhu Jin, Wei Sun, Yong-Xiang Zou, Jing Lin, Hua-Lin Fu, Wei-Lin Jin
Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization. Cancer science 109 (7) (2018)
Jing Lin, Aihui Ji, Guanzhong Qiu, Huaizhi Feng, Jian Li, Shuo Li, Yongxiang Zou, Yong Cui, Chaoli Song, Hua He, Yicheng Lu
FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells. Cancer science 109 (4) (2018)